Public Health

Below please find the Lab's research projects and findings on institutional corruption in the field of public health, in various media.

Blog

New Prescription Drugs: A Major Health Risk With Few Offsetting Advantages

by Donald W. Light

Few people know that new prescription drugs have a 1 in 5 chance of causing serious reactions after they have been approved. That is why expert physicians recommend not taking new drugs for at least five years unless patients have first tried better-established options, and have the need to do so.Read more about New Prescription Drugs: A Major Health Risk With Few Offsetting Advantages

All Public Health Blog Posts
Working Papers
All Public Health Working Papers
Research Projects

The Political Economy of Pharmaceutical Corruption: How to Reconcile Profits and Public Health in the Pharaceutical Sector?

Professor Marc-Andre Gagnon investigates how the innovation system in the pharmaceutical sector is broken. In the last 15 years, fewer new drugs have arrived on the market, and the vast majority of them do not represent any therapeutic advancement as compared to what already exist. However, promotional expenditures surged during that period and, according to dominant pharmaceutical companies' annual reports, they are gaining record profits in spite of the lack of therapeutic innovation.

All Public Health Research Projects